ArticleFrontiers in oncology2021

Clinicopathological and Preclinical Patient-Derived Model Studies Define High Expression of NRN1 as a Diagnostic and Therapeutic Target for Clear Cell Renal Cell Carcinoma.

Shuhei Kamada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.